Trupanion, Inc. (NASDAQ:TRUP) Receives Consensus Rating of “Moderate Buy” from Analysts

Trupanion, Inc. (NASDAQ:TRUP) has been assigned an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $44.67.

A number of analysts recently commented on the company. Northland Securities lifted their price objective on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Bank of America lifted their price target on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Stifel Nicolaus upped their price objective on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Finally, Piper Sandler raised their price objective on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st.

Insider Buying and Selling

In other news, Director Murray B. Low sold 2,000 shares of Trupanion stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $52.67, for a total value of $105,340.00. Following the transaction, the director now directly owns 131,513 shares of the company’s stock, valued at $6,926,789.71. The trade was a 1.50 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Fawwad Qureshi sold 622 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total transaction of $32,723.42. Following the sale, the chief financial officer now owns 9,867 shares of the company’s stock, valued at approximately $519,102.87. This represents a 5.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 28,405 shares of company stock valued at $1,512,482. Insiders own 5.50% of the company’s stock.

Institutional Trading of Trupanion

Hedge funds have recently made changes to their positions in the company. FMR LLC grew its stake in Trupanion by 55,963.7% during the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after purchasing an additional 1,170,202 shares in the last quarter. Renaissance Technologies LLC bought a new stake in Trupanion during the second quarter valued at $4,739,000. Wellington Management Group LLP raised its holdings in shares of Trupanion by 4.4% during the third quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock worth $142,475,000 after purchasing an additional 142,156 shares during the period. Hosking Partners LLP acquired a new stake in shares of Trupanion during the second quarter worth $3,523,000. Finally, Marshall Wace LLP lifted its position in shares of Trupanion by 11.9% in the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after buying an additional 116,496 shares during the last quarter.

Trupanion Stock Performance

Shares of TRUP opened at $50.73 on Friday. Trupanion has a 12-month low of $19.69 and a 12-month high of $57.90. The stock has a market cap of $2.15 billion, a P/E ratio of -158.53 and a beta of 1.60. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The company has a 50-day moving average of $52.92 and a two-hundred day moving average of $42.69.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.09. The firm had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The company’s quarterly revenue was up 14.6% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.10) EPS. As a group, research analysts predict that Trupanion will post -0.23 EPS for the current fiscal year.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.